Lista de

osteonectin
11
"Predictive outcomes for HER2-enriched cancer using growth and metastasis signatures driven by SPARC" (2017) Guttlein, L.N.;Benedetti, L.G.;Fresno, C. (...)Podhajcer, O.L. Molecular Cancer Research. 15(3):304-316
"Predictive outcomes for HER2-enriched cancer using growth and metastasis signatures driven by SPARC" (2017) Guttlein, L.N.;Benedetti, L.G.;Fresno, C. (...)Podhajcer, O.L. Molecular Cancer Research. 15(3):304-316
"Predictive outcomes for HER2-enriched cancer using growth and metastasis signatures driven by SPARC" (2017) Guttlein, L.N.;Benedetti, L.G.;Fresno, C. (...)Podhajcer, O.L. Molecular Cancer Research. 15(3):304-316
"Hippocampal SPARC regulates depression-related behavior" (2012) Campolongo, M.;Benedetti, L.;Podhajcer, O.L. (...)Depino, A.M. Genes, Brain and Behavior. 11(8):966-976
"Hippocampal SPARC regulates depression-related behavior" (2012) Campolongo, M.;Benedetti, L.;Podhajcer, O.L. (...)Depino, A.M. Genes, Brain and Behavior. 11(8):966-976
"Hippocampal SPARC regulates depression-related behavior" (2012) Campolongo, M.;Benedetti, L.;Podhajcer, O.L. (...)Depino, A.M. Genes, Brain and Behavior. 11(8):966-976
"Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells" (1997) Fernanda Ledda, M.;Adris, S.;Bravo, A.I. (...)Podhajcer, O.L. Nature Medicine. 3(2):171-176
"Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells" (1997) Fernanda Ledda, M.;Adris, S.;Bravo, A.I. (...)Podhajcer, O.L. Nature Medicine. 3(2):171-176